1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
636A0549616315C7C85258199006FA1F4
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-benchmarking-quality-in-the-healthcare-sector-adding-value-and-balancing-risk?opendocument
18
19opendocument
2018.212.222.217
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Quality, Compliance and Regulatory Assuring Quality Programs

Benchmarking Quality in the Healthcare Sector: Adding Value and Balancing Risk

ID: 5476


Features:

7 Info Graphics

17 Data Graphics

100+ Metrics


Pages/Slides: 33


Published: 2017


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Benchmarking Quality in the Healthcare Sector: Adding Value and Balancing Risk"

STUDY OVERVIEW


Biopharmaceutical and medical device companies spend millions to ensure their products meet quality standards at every stage of the product life cycle. Facing tight budgets and escalating regulations, quality leaders face a balancing act between ensuring product quality and safety and adding value for patients and healthcare providers.

Best Practices, LLC conducted this study to probe ways in which high-performing quality groups are adding value and balancing risk. It addresses how these companies integrate quality into their strategic focus and priorities; use quality dashboards for executive communication; and use learnings from the medical device sector to inform quality improvements at biopharma companies.

Quality leaders can use this study to assess their quality practices, strategic focus, and risk management.

KEY TOPICS

  • Quality Group’s Focus & Priorities
  • Adding Value and Balancing Risk
  • Quality Dashboard
  • Learning from Medical Devices

SAMPLE KEY METRICS

  • Frequency of practices associated with quality governance
  • Rating of quality performance in areas contributing to the company's strategy
  • Importance level of quality objectives
  • Quality function's maturity level in areas affecting the company's strategy
  • Importance level for risk management dimensions
  • Frequency of quality dashboard presentations to leadership groups
  • Effectiveness rating for quality metrics used to summarize performance to leadership

SAMPLE KEY FINDINGS

  • Extend Quality planning, operations and management systems to support senior leadership.
  • Patient-focus Drives Quality Decision-making — But Doesn’t Bridge To Improved Safety & Efficacy.

METHODOLOGY


The research employed a data gathering approach that reaps quantitative & qualitative data from
a diverse group of 22 companies. This study includes segmented data for biopharma and medical device companies.

Industries Profiled:
Medical Device; Pharmaceutical; Diagnostic; Manufacturing; Consulting; Biotech; Biopharmaceutical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Boston Scientific; idera pharmaceuticals; Astellas; seracare; GlaxoSmithKline ; GN Hearing; 3M Company; Neopharm; Amgen; NewLink Genetics; Abbvie; Takeda Pharmaceuticals; Daiichi Sankyo; DePuy Synthes; Baxter Healthcare; Novartis; Tesaro; Biogen; Sanofi; Abbott; Medtronic; Beckman Coulter


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.